Bibliography
- Calabresi L, Baldassarre D, Castelnuovo S et al.: Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 120, 628–635 (2009).
- Hovingh GK, Hutten BA, Holleboom AG et al.: Compromised LCAT function is associated with increased atherosclerosis. Circulation 112, 879–884 (2005).
- Tanigawa H, Billheimer JT, Tohyama J et al.: Lecithin:cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo. Circulation 120, 160–169 (2009).
- Calabresi L, Pisciotta L, Costantin A et al.: The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler. Thromb. Vasc. Biol. 25, 1972–1978 (2005).
- Amato M, Montorsi P, Ravani A et al.: Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur. Heart J. 28, 2094–2101 (2007).
- O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340, 14–22 (1999).
- Barter PJ, Caulfield M, Eriksson M et al.: Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357, 2109–2122 (2007).
- Frikke-Schmidt R, Nordestgaard BG, Stene MC et al.: Association of loss-offunction mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 299, 2524–2532 (2008).
- Humphries SE, Morgan L: Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol. 3, 227–235 (2004).
- Kathiresan S, Willer CJ, Peloso GM et al.: Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56–65 (2009).
- Ng DS, Maguire GF, Wylie J et al.: Oxidative stress is markedly elevated in lecithin:cholesterol acyltransferase-deficient mice and is paradoxically reversed in the apolipoprotein E knockout background in association with a reduction in atherosclerosis. J. Biol. Chem. 277, 11715–11720 (2002).
- Furbee JW Jr, Sawyer JK, Parks JS: Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice. J. Biol. Chem. 277, 3511–3519 (2002).
- Berard AM, Foger B, Remaley A et al.: High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithincholesteryl acyltransferase. Nat. Med. 3, 744–749 (1997).
- Hoeg JM, Santamarina-Fojo S, Berard AM et al.: Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl Acad. Sci. USA 93, 11448–11453 (1996).
- Asztalos BF, Schaefer EJ, Horvath KV et al.: Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J. Lipid Res. 48, 592–599 (2007).